Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review

by H. Alsdurf, B. Empringham, C. Miller, A. Zwerling
Published 2021-09-01

Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis

by David W. Dowdy, Alice A. Zwerling, Andrea Stennett, Alexandra Searle, Vadim Dukhanin, Holly A. Taylor, Maria W. Merritt
Published 2020-04-01

Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country

by K. Sullivan, C. Pease, A. Zwerling, R. Mallick, D. Van Dyk, S. Mulpuru, C. Allen, H. Alsdurf, G. G. Alvarez
Published 2021-05-01

The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study

by G. G. Alvarez, D. Van Dyk, R. Mallick, S. Lesperance, P. Demaio, S. Finn, S. Edmunds Potvin, M. Patterson, C. Pease, K. Amaratunga, C. Hui, D.W. Cameron, S. Mulpuru, S.D. Aaron, F. Momoli, A. Zwerling
Published 2020-01-01